Steven P. Weinstein

Rilonacept (interleukin-1 trap) in the prevention of acute gout flares during initiation of urate-lowering therapy: results of a phase II randomized, double-blind, placebo-controlled trial.

R. Terkeltaub, Y. Soo, G. Yancopoulos, 2012, Arthritis and rheumatism.

Rilonacept for gout flare prevention during initiation of uric acid-lowering therapy: results from the PRESURGE-2 international, phase 3, randomized, placebo-controlled trial.

G. Yancopoulos, H. Schumacher, S. Luo, 2013, Rheumatology.

Efficacy and safety of dupilumab in adults with moderate-to-severe atopic dermatitis inadequately controlled by topical treatments: a randomised, placebo-controlled, dose-ranging phase 2b trial

E. R. Sutherland, T. Bieber, G. Yancopoulos, 2016, The Lancet.